<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04955756</url>
  </required_header>
  <id_info>
    <org_study_id>ESAR</org_study_id>
    <nct_id>NCT04955756</nct_id>
  </id_info>
  <brief_title>Early Identification and Severity Prediction of Acute Respiratory Infectious Disease</brief_title>
  <acronym>ESAR</acronym>
  <official_title>Early Identification and Severity Prediction of Acute Respiratory Infectious Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huashan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huashan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Early identification and Severity prediction of Acute Respiratory infectious disease has&#xD;
      become a top priority for clinicians at department of infectious and respiratory diseases&#xD;
      after COVID-19 broke out. This is a multicenter, prospective, and randomized study, which&#xD;
      aims to figure out the best way of early identification and severity prediction of acute&#xD;
      respiratory infectious diseases. Patients with suspected acute respiratory infectious&#xD;
      diseases will be enrolled into this study and received two different diagnostic pathways.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 4, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time for targetted antibiotic treatment</measure>
    <time_frame>28 days</time_frame>
    <description>time interval from enrollment to targetted antibiotic treatment initiation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence for clinical key events</measure>
    <time_frame>28 days</time_frame>
    <description>Incidence for clinical events including tracheal intubation, tracheotomy, ECMO, and CRRT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence for clinical remission</measure>
    <time_frame>28 days</time_frame>
    <description>Incidence for clinical remission, which achieve the following conditions for over 24 hours: ① heart rate &lt;100bpm; ② SBP&gt; 90mmHg; ③Body Temperature &lt;38℃; ④ SaO2 &gt; 90% at room temperature;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization;</measure>
    <time_frame>28 days</time_frame>
    <description>time interval between admission to hispital and discharge from the hospital when a participant is recovered</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU admission</measure>
    <time_frame>28 days</time_frame>
    <description>time interval from admission to ICU and discharge from ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length from admission to clinical events</measure>
    <time_frame>28 days</time_frame>
    <description>time interval from admission to hospital to clinical events including tracheal intubation, tracheotomy, ECMO, and CRRT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sampling to Diagnosis Interval</measure>
    <time_frame>28 days</time_frame>
    <description>time interval from Sampling to Diagnosis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Acute Respiratory Infection</condition>
  <condition>Severe Pneumonia</condition>
  <condition>Next Generation Sequencing</condition>
  <condition>Multiplex PCR</condition>
  <arm_group>
    <arm_group_label>mNGS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>PCR group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>mNGS</intervention_name>
    <description>Participants will be randomized to receive mNGS or multiplex PCR for diagnosis at enrollment.</description>
    <arm_group_label>mNGS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Multiplex PCR</intervention_name>
    <description>Participants will be randomized to receive mNGS or multiplex PCR for diagnosis at enrollment.</description>
    <arm_group_label>PCR group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients aged between 18 and 80 years old&#xD;
&#xD;
          2. No limits in gender&#xD;
&#xD;
          3. Patients who are newly present with cough, sputum, or exacerbated with pyogenic&#xD;
             sputum, with or without chest pain within 2 weeks;&#xD;
&#xD;
          4. Patients who meet at least one of the following 4 requirements:&#xD;
&#xD;
               1. fever;&#xD;
&#xD;
               2. Sign of pulmonary consolidation or wet wales&#xD;
&#xD;
               3. WBC&gt;10×10^9/L or &lt;4×10^9/L;&#xD;
&#xD;
               4. patchy, infiltrating shadows or interstitial changes, with or without pleural&#xD;
                  effusion on chest radiological examination.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Highly suspected or diagnosed pulmonary non-infectious disease (Tumor, Immune disease,&#xD;
             etc.) without evidence for infection;&#xD;
&#xD;
          2. Pathogen has been identified without evidence for co-infection;&#xD;
&#xD;
          3. Insufficiency of respiratory and blood samples;&#xD;
&#xD;
          4. Patients who are unable to collaborate due to physical or mental disorders;&#xD;
&#xD;
          5. Patients who have been engaged to other clinical trials;&#xD;
&#xD;
          6. Any conditions make it unsafe for the subject to participate;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wenhong Zhang, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Infectious disease, Huashan Hospital, Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hongyu Wang, Dr</last_name>
    <phone>17717366509</phone>
    <email>wubywang961208@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jingwen Ai, Dr</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Central Hospital of Jingan District</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wenhong Zhang, Prof</last_name>
      <phone>021-61578000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Infectious Disease, Huashan Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongyu Wang</last_name>
      <phone>17717366509</phone>
      <email>rubywang961208@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Hospital of Minhang District</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>201103</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiang Li, Prof</last_name>
      <phone>021-64923400</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 18, 2021</study_first_submitted>
  <study_first_submitted_qc>July 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2021</study_first_posted>
  <last_update_submitted>July 7, 2021</last_update_submitted>
  <last_update_submitted_qc>July 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huashan Hospital</investigator_affiliation>
    <investigator_full_name>Wen-hong Zhang</investigator_full_name>
    <investigator_title>chairman of the infectious disease department</investigator_title>
  </responsible_party>
  <keyword>mNGS</keyword>
  <keyword>Multiplex PCR</keyword>
  <keyword>Acute Respiratory Infectious Disease</keyword>
  <keyword>Severe Pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

